Underreporting of adverse drug reactions (ADRs) is an international patient safety problem. This systematic review of studies assessed how various strategies designed to improve ADR reporting impacted ADR rates. While all strategies increased ADR reporting, particularly those using electronic reporting tools, the quality of the studies was generally low. The authors expressed the need for higher quality studies to focus on how electronic methods might improve ADR reporting.